AMENDMENT NO. 1 TO 2013 SECURITIES PURCHASE AGREEMENT

Contract Categories: Business Finance - Purchase Agreements
EX-10.2 3 v367400_ex10-2.htm EXHIBIT 10.2

 

Exhibit 10.2

 

AMENDMENT NO. 1 TO

 

2013 SECURITIES PURCHASE AGREEMENT

 

This Amendment No. 1 (this “Amendment”), dated as of January 29, 2014, is by and among Champions Oncology, Inc. (the “Company”), Battery Ventures IX, L.P. (“Ventures”), Battery Investment Partners IX, LLC (together with Ventures, “Battery”) and PAR Investment Partners, L.P. (“PAR”).

 

WHEREAS, the Company, Battery, PAR and certain other parties are parties to the Securities Purchase Agreement (the “Securities Purchase Agreement”) dated as of January 28, 2013; and

 

WHEREAS, the Company, Battery and PAR wish to amend certain provisions of the Securities Purchase Agreement;

 

NOW, THEREFORE, in consideration of the mutual promises made herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and each of Battery and PAR hereby agree as follows.

 

1.          The definition of “Change of Control” in Section 1.3 of the Securities Purchase Agreement is hereby replaced in its entirety with the following:

 

Change of Control” means the occurrence of any one or more of the following events: (i) the sale or other disposition to an unrelated party of all or substantially all of the assets of the Company, in one transaction or a series of transactions (other than financing arrangements); or (ii) a merger, consolidation or share exchange involving the Company and any other person or entity (other than for the purposes of reincorporation), in which the Company or one of its subsidiaries is not the surviving entity, after approval of the Board of Directors.

 

2.          All other provisions of the Securities Purchase Agreement shall remain intact. This Amendment shall be interpreted in accordance with the governing law and jurisdiction provisions of Section 6.7 of the Securities Purchase Agreement. This Amendment may be executed in any number of counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. This Amendment may be executed and delivered by facsimile transmission or email.

 

[Remainder of page intentionally left blank]

 

 
 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first written above.

 

  CHAMPIONS ONCOLOGY, INC.  
     
           
  By: /s/ Joel Ackerman  
  Name: Joel Ackerman  
  Title:   Chief Executive Officer  
           
           
           
  BATTERY VENTURES IX, L.P.  
     
  By: Battery Partners IX, LLC  
    General Partner  
           
           
    By: /s/ Scott Tobin  
    Name: Scott Tobin  
    Title:   Member Manager  
           
           
           
  BATTERY INVESTMENT PARTNERS, IX, LLC  
     
  By: Battery Partners IX, LLC  
    Managing Member  
       
           
    By: /s/ Scott Tobin  
    Name: Scott Tobin  
      Title:   Member Manager  
           
           
           
  PAR INVESTMENT PARTNERS, L.P.  
     
  By: PAR Group, L.P.  
    General Partner  
       
    By: PAR Capital Management, Inc.  
      General Partner  
           
      By: Steven Smith  
        Name: Steven M. Smith  
        Title: Chief Operating Officer